Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

A month has gone by since the last earnings report for Medtronic (MDT). Shares have added about 0.7% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...

Bridgewater Associates is loading up on shares of ExxonMobil, Medtronic, and Microsoft. Here's what you need to know.

The Federal Circuit revived a lawsuit against Medtronic Inc. over guide catheter technology Monday, ruling that a district ...

A medical supplier has been ordered to pay millions in the largest-ever penalty in Australia for unlawfully supplying more ...

Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy Axonics, which was announced in January.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Strategics tend to invest in med-tech companies they are looking to acquire or could be acquired. Furthermore, companies like ...

Medtronic faced challenges, including poor focus, lack of innovation, and COVID-19 impact, leading to share price stagnation since 2018. Despite recent improvements in performance, Medtronic ...

The analysis comes as regulators investigate how the FDA authorizes medical devices and handles safety recalls.

Recommended Reading Medtronic asks ITC to stop sales, imports of Axonics devices A California jury ruled on Wednesday that Axonics did not infringe three of Medtronic’s patents related to sacral ...